Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower back pain, neck pain, shoulder pain, knee pain, tennis elbow, to joint pain, temporomandibular joint disorders, upper back pain, and wounds. The company was formerly known as Erika B-Cure Laser Ltd and changed its name to Erika Carmel-Tech Ltd in October 2025. Erika Carmel-Tech Ltd was incorporated in 2007 and is headquartered in Haifa, Israel.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is underpriced on P/FCF.
Buy
Sell